Ms. Leann M Rowland Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 146 Mountain Ave, Piscataway, NJ 08854 Phone: 855-515-5700 |
Mary Lally Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 671 Hoes Ln W, Piscataway, NJ 08854 Phone: 800-969-5300 |
Farooq Alihassan Counselor Medicare: Not Enrolled in Medicare Practice Location: 10 Corporate Pl S, Piscataway, NJ 08854 Phone: 732-235-4404 |
Debra Panciello, LAC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 671 Hoes Lane West, Piscataway, NJ 08855 Phone: 732-235-4434 |
Ms. Evelyn Jean Jeffrey, LCSW Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 214 Hampshire Ct, Piscataway, NJ 08854 Phone: 732-235-1451 |
Aarti Mathur Counselor Medicare: Not Enrolled in Medicare Practice Location: 671 Hoes Ln W, Piscataway, NJ 08854 Phone: 732-235-5700 Fax: 732-235-6038 |
Mary A Keller, LPC Counselor - Addiction (Substance Use Disorder) Medicare: Medicare Enrolled Practice Location: 671 Hoes Ln, Piscataway, NJ 08854 Phone: 800-969-5300 |
Karen Johnson Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 671 Hoes Ln W, Piscataway, NJ 08854 Phone: 800-969-5300 |
Laverne Maxwell Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 671 Hoes Ln W, Piscataway, NJ 08854 Phone: 732-235-6184 |
Miss Paola A Ricardo Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 151 Centennial Ave, Piscataway, NJ 08854 Phone: 732-235-4404 |
Katherine Lacson Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 671 Hoes Ln W, Piscataway, NJ 08854 Phone: 800-969-5300 |
Mr. Sean Valverde Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 151 Centennial Ave, Piscataway, NJ 08854 Phone: 201-674-4990 |
Samantha Brenner Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 671 Hoes Ln W, Piscataway, NJ 08854 Phone: 800-969-5300 |
Vanessa Martinez Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 151 Centennial Ave, Piscataway, NJ 08854 Phone: 800-969-5300 |
Mr. Alexander Miles, LAC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 671 Hoes Ln W, Piscataway, NJ 08854 Phone: 732-234-3289 |
Ashley Tiberi Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 671 Hoes Ln W, Piscataway, NJ 08854 Phone: 855-575-5700 |
Christine Torres Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 671 Hoes Ln W, Piscataway, NJ 08854 Phone: 800-969-5300 |
Mr. Vincent Muse Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 151 Centennial Ave, Piscataway, NJ 08854 Phone: 732-235-6184 Fax: 732-235-7221 |
Kelly C Rodriguez Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 671 Hoes Ln W, Piscataway, NJ 08854 Phone: 800-969-5300 |
Jennifer Ortiz Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 671 Hoes Ln W, Piscataway, NJ 08854 Phone: 800-969-5300 |
News Archive
According to Dr. Ila R. Singh, an associate professor of pathology at the University of Utah, "for the first time we have analyzed prostate cancer and normal prostate tissue and found cancers are much more likely to have [the XMRV virus] ... It was also more likely to be present in more aggressive tumors," Singh said. "We found it in 20 percent of the least aggressive tumors and over 45 percent of the most aggressive tumors."
POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, presented positive results from two pivotal Phase 3 clinical trials of the investigational product, PA32540, at The American Heart Association (AHA) Scientific Sessions 2012, as Poster #12057: Treatment Continuation and Cardiovascular Safety of Antiplatelet Therapy with PA32540, A Tablet with Enteric-Coated Aspirin and Immediate-Release Omeprazole: Results of Two 6-Month, Phase 3 Studies.
Sirnaomics, Inc. and its affiliate Suzhou Sirnaomics Pharmaceutics, Co. Ltd., together with its partner Guangzhou Xiangxue Pharmaceutical, Co. Ltd., (SZSE: 300147), have formally submitted an Investigational New Drug (IND) Application to the China Food and Drug Administration for STP705, an anti-fibrosis RNA interference (RNAi) therapeutic for prevention and treatment of human skin hypertrophic scars.
NephRx Corporation today announced issuance of a new U.S. patent for its novel peptide NX002, which currently is in preclinical development for the treatment of oral mucositis.
› Verified 6 days ago